Product Launch (Blog)

Oct, 05 2023

Stem Cell Therapy: Revolutionizing Healthcare

Stem cell therapy, a form of regenerative medicine, aims to repair damaged cells by reducing inflammation and modulating the immune system. This therapeutic approach has shown effectiveness in addressing various ailments. Extensive research has been conducted on stem cell therapies for conditions such as Crohn's disease, Multiple Sclerosis, Lupus, COPD, Parkinson's, ALS, stroke recovery, and more. Moreover, stem cell therapies have demonstrated potential in treating autoimmune, inflammatory, neurological, orthopedic, and traumatic disorders.

According to Data Bridge Market Research, Stem Cell Therapy Market accounted for USD 257 million in 2022, and expected to reach USD 921.12 million by 2030. The market is expected to grow with a CAGR of 17.3% in the forecast period of 2023 to 2030.

“The growing need for potent treatments will propel the market growth”

Substantial investments in research and development (R&D) serve as a significant driver for market expansion. Furthermore, the increasing demand for effective treatments to alleviate the burden of diseases contributes to the growth. For instance, Celavie Biosciences is conducting an ongoing 5-year exploratory study on Parkinson's disease as of May 2020. The company is focused on developing regenerative stem cell therapies for the treatment of Parkinson's disease and other central nervous system disorders and thus drives the market.

What restraints the growth of the stem cell therapy market?

“The high cost of treatment hinders the market expansion”

The high cost of cell treatments has hindered the expansion of the cell treatment market. Despite the increasing demand for these therapies as a popular treatment option, they remain prohibitively expensive. Simple joint injections can cost up to $1,000, while more complex procedures can reach up to $100,000. In the United States, the average cost of stem cell therapy per patient is estimated to be between $4,000 and $8,000 in 2020. Consequently, the high treatment cost acts as a limiting factor for the growth of the stem cell therapy market.

Segmentation: Global Stem Cell Therapy Market

The stem cell therapy market is segmented on the basis of product type, type, distribution channel, end-user, and application.

  • On the basis of product type, the stem cell therapy market is segmented into bone marrow derived mesenchymal cells, placental or umbilical stem cell, adipose tissue derived mesenchymal stem cells, and others.
  • On the basis of type, the stem cell therapy market is segmented into allogenic stem cell therapy and autologous stem cell therapy.
  • On the basis of distribution channel, the stem cell therapy market is segmented into direct tender, third party distributors.
  • On the basis of end-user, the stem cell therapy market is segmented into hospitals and surgical centers, therapeutic companies, services companies, and others.
  • On the basis of application, the stem cell therapy market is segmented into musculoskeletal disorders, acute graft-versus-host disease (AGVHD), wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and others.

Regional Insights: North America dominates the Stem Cell Therapy Market

North America dominates the global stem cell therapy market because of the region's well-developed healthcare infrastructure and favorable reimbursement policies. Another factor contributing to the region's growth is the number of government initiatives to promote stem cell therapy.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030, owing to the growing incidence of cancer cases, rising technological advancements, and rising prevalence of chronic diseases such as diabetes, cancer, and neurological disorders.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-stem-cell-therapy-market

Recent Developments

  • In 2021, A worldwide licensed agreement and strategic collaboration between Minovia Therapeutics, Ltd. and Astellas Pharma, Inc. was established for the development of cutting-edge stem cell therapy programs for illnesses brought on by mitochondrial malfunction. The partnership intends to accelerate the development of allogeneic mitochondrial cell therapy initiatives. The two businesses will collaborate to investigate potential cell treatment program prospects using Astellas' genetically modified, induced pluripotent stem cells and Minovia's MAT platform technology.

The Prominent Key Players Operating in the Stem Cell Therapy Market Include:

  • Athersys Inc. (U.S.)
  • Mesoblast Ltd (Australia)
  • Biorestorative Therapies Inc. (U.S.)
  • Pluristem Inc. (Israel)
  • Brainstorm Cell Limited. (U.S.)
  • ViaCyte Inc. (U.S.)
  • Gamida Cell (U.S.)
  • HOPE BIOSCIENCES (U.S.)
  • Cellular Biomedicine Group (U.S.)
  • Smith+Nephew (U.K.)
  • MEDIPOST (South Korea)
  • ANTEROGEN. C.O., LTD. (South Korea)
  • NuVasive Inc. (U.S.)
  • RTI Surgical (U.S.)
  • AlloSource (U.S.)
  • JCR Pharmaceuticals Co. Ltd. (Japan)
  • Takeda Pharmaceutical Company Limited (Japan)

Above are the key players covered in the report, to know about more and exhaustive list of stem cell therapy market companies contact, https://www.databridgemarketresearch.com/contact

Research Methodology: Global Stem Cell Therapy Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials